Guidelines of care for the management of basal cell carcinoma

Academic Article


  • © 2017 American Academy of Dermatology, Inc. Basal cell carcinoma (BCC) is the most common form of human cancer, with a continually increasing annual incidence in the United States. When diagnosed early, the majority of BCCs are readily treated with office-based therapy, which is highly curative. In these evidence-based guidelines of care, we provide recommendations for the management of patients with BCC, as well as an in-depth review of the best available literature in support of these recommendations. We discuss biopsy techniques for a clinically suspicious lesion and offer recommendations for the histopathologic interpretation of BCC. In the absence of a formal staging system, the best available stratification based on risk for recurrence is reviewed. With regard to treatment, we provide recommendations on treatment modalities along a broad therapeutic spectrum, ranging from topical agents and superficially destructive modalities to surgical techniques and systemic therapy. Finally, we review the available literature and provide recommendations on prevention and the most appropriate follow-up for patients in whom BCC has been diagnosed.
  • Digital Object Identifier (doi)

    Author List

  • Bichakjian C; Armstrong A; Baum C; Bordeaux JS; Brown M; Busam KJ; Eisen DB; Iyengar V; Lober C; Margolis DJ
  • Start Page

  • 540
  • End Page

  • 559
  • Volume

  • 78
  • Issue

  • 3